THE Food and Drug Administration (FDA) yesterday warned the public against consuming three unregistered drug products — “OTC Lixiao Zhuangyaojianshen Wan,” “Diclofenac Sodium Sustained Release Capsules 0.1g,” and “OTC Yulin® Shiduqing Jiaonang.”
It said the three products have not gone through the FDA registration process and have not been issued a “proper authorization in the form of a certificate of product registration.”
Malaya Business Insight comes to you in a very readable package: A fusion of in-depth news, excellent news analyses, the credible prognosis of events, powerful commentaries and balanced updates on what is happening and about to happen in corporate board rooms, in the diverse business and industry sectors, in Philippine regional and global politics and in the exciting world of sports, arts, entertainment, and lifestyle.
© 2025 Malaya Business Insight. All Rights Reserved.
Developed by Neitiviti Studios
